Dry Eye: Clinical Trials

9 trials for Dry Eye, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 terminated. 9 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 49Terminated 9

Follow Dry Eye: new trials by email Literature Review of Dry Eye trials Research Report on Dry Eye

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Performance of Systane PRO Versus Refresh Optive Mega-3
Systane PRO, Refresh Optive MEGA-3 - Dry Eye
Phase 4TerminatedScripps Poway Eyecare and Optometry202025-05-152026-04-13
A Study Evaluating the Safety of the Nasal Pump
Tyrvaya Nasal Pump - Dry Eye, Kerato Conjunctivitis Sicca
Phase 4TerminatedOyster Point Pharma, Inc.52024-02-212025-05-02
Effects of Supplementation With PUFAs and Antioxidants for Contact Lens Discomfort
HydroEye® - Dry Eye, Contact Lens Complication
Phase 4TerminatedUniversity of Alabama at Birmingham312022-09-162025-03-06
Safety and Efficacy of Dexamethasone Ophthalmic Insert (Dextenza®) in the Management of Clinically Significant Dry Eye
Sustained Release Dexamethasone, 0.4 mg, E-Caprolactone-L-Lactide copolymer (PCL) punctal plug - Dry Eye
Phase 4TerminatedJohns Hopkins University772021-03-162024-03-15
Intracanalicular Dexamethasone Insert for the Treatment of Inflammation and Discomfort in Dry Eye Disease (DEcIDED)
Dextenza (IDI) (Sustained Release Dexamethasone), (0.4 mg), ProLong™ collagen plugs - Dry Eye
Phase 4TerminatedTufts Medical Center542020-09-042025-01-15
Investigating iLux Efficacy in Contact Lens Wearers With Evaporative Dry Eye Disease
iLux® system - Dry Eye
Phase 4TerminatedUniversity of Waterloo282019-11-152023-05-16
Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests
Preservative-free Refresh Optive Advanced Lubricant Eye Drops - Dry Eye
Phase 4TerminatedTufts Medical Center362019-10-032025-09-22
Azithromycin for Meibomian Gland Disease
Azithromycin Oral Product, Placebo Oral - Dry Eye, Neuropathic Eye Pain
Phase 4TerminatedUniversity of California, San Francisco22019-09-012025-08-06
The Prophylactic Use of Topical Cyclosporine A 0.05% to Prevent Graft Versus Host Disease Related Dry Eye
Cyclosporine A 0.05%, Arificial Tear - Dry Eye
Phase 4TerminatedMassachusetts Eye and Ear Infirmary82007-08-012017-03-28

Narrower conditions

Dry Eye Syndromes (9)  ·  Anxiety Disorders (1)  ·  Depression (1)  ·  Graft vs Host Disease (1)

Broader conditions

Eye Diseases (9)  ·  Lacrimal Apparatus Diseases (9)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Immune System Diseases (1)  ·  Mental Disorders (1)

Interventions

Calcium Dobesilate (2)  ·  Azithromycin (1)  ·  Cyclosporins (1)  ·  Lubricant Eye Drops (1)  ·  Punctal Plugs (1)

Sponsors

Tufts Medical Center (2)  ·  Johns Hopkins University (1)  ·  Massachusetts Eye and Ear Infirmary (1)  ·  Oyster Point Pharma, Inc. (1)  ·  Scripps Poway Eyecare and Optometry (1)  ·  University of Alabama at Birmingham (1)  ·  University of California, San Francisco (1)  ·  University of Waterloo (1)

Countries

United States (8)  ·  Canada (1)

Top investigators

Esen Akpek, MD (1)  ·  Jay Mashouf, OD (1)  ·  Julie Schallhorn, MD, MS (1)  ·  Kelly K Nichols, OD, PhD (1)  ·  Lyndon Jones, PhD, FCOptom (1)  ·  Pedram Hamrah, MD (1)  ·  Reza Dana, M.D. (1)  ·  Stephanie Cox, OD (1)  ·  Thuy Doan, MD, PhD (1)

Results publications

PMID 38492864